together with trends in reductions in Parkinson’s medications (levodopa-equivalent daily dose [LEDD]). 1 Most participants in the mild PD cohort showed an overall stable clinical status with little ...
AbbVie's growth thrives on strong earnings, a robust immunology portfolio, and diversification. See why ABBV stock is a ...
15h
Study did not demonstrate statistically significant improvement on primary endpoint of reduction in depressive symptoms as measured by MADRS ...
Parkinson's Disease Treatment Market Aging Populations and Advancements in Deep Brain Stimulation, Gene Therapy, and Medications Fuel Marke ...
GOTHENBURG, SWEDEN / ACCESS Newswire / February 17, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA)/ IRLAB Therapeutics AB , a company discovering and developing novel treatments for Parkinson's ...
Discover seven companies operating in metabolomics, the field that could significantly boost precision medicine.
GOTHENBURG, SWEDEN / ACCESS Newswire / February 17, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA)/ IRLAB Therapeutics AB (Nasdaq Stockholm:IRLAB A), a company discovering and developing novel trea ...
In his regular column, Dr James Le Fanu answers your questions. This week, a reader is concerned by a neighbour who is ...
Addex Therapeutics Ltd (NASDAQ:ADXN – Get Free Report) was the target of a significant decline in short interest in the month of January. As of January 31st, there was short interest totalling 1,500 ...
Clinical studies have revealed that rasagiline is associated with improved outcomes in patients with early Parkinson's disease (PD) and also reduces "off" time in patients with moderate to ...
There are many good men but that’s not the point. All it takes is one bad one, one look to make your insides drop ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback